C9orf72突变携带者的疾病进展
结果显示这三种指标在诊断亚组间存在差异,并在有症状患者中随随访恶化,且恶化斜率因亚组而异;ALS和ALS-FTD患者的生存率在12和18个月随访中下降。
要点
- ALSFRS-R、字母流畅性和FBI可区分C9orf72携带者的ALS、ALS-FTD、FTD和无症状表型。
- 有症状C9orf72携带者的上述三项指标随疾病进展而恶化,且不同表型恶化斜率不同。
- C9orf72相关ALS和ALS-FTD患者的生存率在12和18个月随访中下降。
核心结论
- ALSFRS-R、字母流畅性和FBI的评分模式可区分C9orf72突变携带者的ALS、ALS-FTD、FTD和 asymptomatic 表型。
- 纵向变化与疾病进展一致,且恶化模式与就诊时表型相符。
研究设计与样本
- 参与者根据临床诊断标准分为无症状、ALS、ALS-FTD或行为变异型FTD。
- 在基线和6、12、18个月随访时进行ALSFRS-R、字母流畅性和FBI评估,诊断性认知和运动测试在6和18个月重复。
主要发现
- 大多数患者的临床诊断在随访期间未发生变化。
- ALSFRS-R评分与运动功能指标相关,字母流畅性与FBI和认知测试相关。
- ALSFRS-R、字母流畅性和FBI在入组时因C9orf72诊断亚组而异,并在有症状患者中随随访恶化,亚组间斜率不同。
- 大多数患者存活至入组后6个月时间点。
- C9orf72相关ALS和ALS-FTD患者的生存率在12和18个月随访中下降。
临床怎么用
- 在C9orf72突变携带者的临床随访中,可连续使用ALSFRS-R、字母流畅性和FBI来监测疾病进展。
- 上述指标有助于区分不同临床表型,并可能反映表型特异性恶化轨迹。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess changes in 3 clinical measures, the Revised ALS Functional Rating Scale (ALSFRS-R), letter fluency, and Frontal Behavioral Inventory (FBI), over time in C9orf72 mutation carriers (C9+) with varied clinical phenotypes. METHODS: Thirty-four unrelated participants with mutations in C9orf72 were enrolled in a prospective natural history study. Participants were classified as asymptomatic, amyotrophic lateral sclerosis (ALS), ALS-familial frontotemporal dementia (FTD), or behavioral-variant FTD by clinical diagnostic criteria. Diagnostic cognitive and motor tests were repeated at 6 and 18 months. The ALSFRS-R, letter fluency, and FBI were administered at baseline and follow-up visits at 6, 12, and 18 months. RESULTS: The clinical diagnosis of most patients did not change over the follow-up. ALSFRS-R scores correlated with measures of motor function. Letter fluency correlated with FBI and cognitive tests. ALSFRS-R, letter fluency, and FBI differed among the C9+ diagnostic subgroups at enrollment and worsened over follow-up in symptomatic patients, with different slopes among the subgroups. Most patients survived to the 6-month time point after enrollment. Survival of C9+ patients with ALS and C9+ patients with ALS-FTD declined over the 12- and 18-month follow-up. CONCLUSIONS: The pattern of scores of the ALSFRS-R, letter fluency, and FBI distinguished between ALS, ALS-FTD, and FTD presentations of C9orf72 mutation carriers and asymptomatic carriers. Longitudinal changes in these measures occurred with disease progression in a manner consistent with presenting phenotype.
引用
- Floeter MK, Traynor BJ, Farren J, et al. Disease progression in C9orf72 mutation carriers. Neurology. 2017. PMID: 28615433. doi:10.1212/WNL.0000000000004115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。